CVE-2024-27083

Flask-AppBuilder's OAuth login page subject to Cross Site Scripting (XSS)

Description

Flask-AppBuilder is an application development framework, built on top of Flask. A Cross-Site Scripting (XSS) vulnerability has been discovered on the OAuth login page. An attacker could trick a user to follow a specially crafted URL to the OAuth login page. This URL could inject and execute malicious javascript code that would get executed on the user's browser. This issue was introduced on 4.1.4 and patched on 4.2.1.

Category

4.3
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.63%
Vendor Advisory github.com
Affected: dpgaspar Flask-AppBuilder
Published at:
Updated at:

References

Link Tags
https://github.com/dpgaspar/Flask-AppBuilder/security/advisories/GHSA-fqxj-46wg-9v84 vendor advisory
https://github.com/dpgaspar/Flask-AppBuilder/commit/3d17741886e4b3c384d0570de69689e4117aa812 patch

Frequently Asked Questions

What is the severity of CVE-2024-27083?
CVE-2024-27083 has been scored as a medium severity vulnerability.
How to fix CVE-2024-27083?
To fix CVE-2024-27083, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-27083 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-27083 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-27083?
CVE-2024-27083 affects dpgaspar Flask-AppBuilder.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.